Literature DB >> 17653440

Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study.

O A Nascimento1, A Camelier, F W Rosa, A M B Menezes, R Pérez-Padilla, J R Jardim.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a common disease in adults over 40 years of age and has a great social and economic impact. It remains little recognized and undertreated even in developed countries. However, there are no data about its diagnosis and treatment in Brazil. The objectives of the present study were to evaluate the proportion of COPD patients who had never been diagnosed and to determine if the COPD patients who had been identified were receiving appropriate treatment. The Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) was a randomized epidemiological study of adults over 40 years living in five metropolitan areas, including São Paulo. The studied sample was randomly selected from the population after a division of the metropolitan area of São Paulo in clusters according to social characteristics. All subjects answered a standardized questionnaire on respiratory symptoms, history of smoking, previous diagnosis of lung disease, and treatments. All subjects performed spirometry. The criterion for the diagnosis of COPD was defined by a post-bronchodilator FEV1/FVC ratio lower than 0.7. A total of 918 subjects were evaluated and 144 (15.8%) met the diagnostic criterion for COPD. However, 126 individuals (87.5%) had never been diagnosed. This undiagnosed group of COPD patients had a lower proportion of subjects with respiratory symptoms than the previously diagnosed patients (88.9 vs 54.8%) and showed better lung function with greater FEV1 (86.8 +/- 20.8 vs 68.5 +/- 23.6% predicted) and FVC (106.6 +/- 22.4 vs 92.0 +/- 24.1% predicted). Among the COPD patients, only 57.3% were advised to stop smoking and 30.6% received the influenza vaccine. In addition, 82.3% did not receive any pharmacological treatment. In conclusion, COPD is underdiagnosed and a large number of COPD patients are not treated appropriately.

Entities:  

Mesh:

Year:  2007        PMID: 17653440     DOI: 10.1590/s0100-879x2006005000133

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  15 in total

1.  Nipping it in the bud: An inspiring mission for prevention and management of COPD.

Authors:  Nanshan Zhong
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

2.  Prevalence and features of asthma-COPD overlap in the United States 2007-2012.

Authors:  Angelico Mendy; Erick Forno; Theophile Niyonsenga; Ryan Carnahan; Janvier Gasana
Journal:  Clin Respir J       Date:  2018-08       Impact factor: 2.570

Review 3.  Epidemiology and management of common pulmonary diseases in older persons.

Authors:  Kathleen M Akgün; Kristina Crothers; Margaret Pisani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-15       Impact factor: 6.053

4.  Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients.

Authors:  Athanasios Tselebis; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Athanasios Karkanias; Ioannis Ilias; Nikolaos Siafakas; Alexandros Vgontzas; Nikolaos Tzanakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-14       Impact factor: 3.455

5.  Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Authors:  Roy A Pleasants; Khosrow Heidari; Anne G Wheaton; Jill A Ohar; Charlie Strange; Janet B Croft; Winston Liao; David M Mannino; Monica Kraft
Journal:  COPD       Date:  2015-09-14       Impact factor: 2.409

6.  PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: the problem of underdiagnosis.

Authors:  Graciane Laender Moreira; Beatriz Martins Manzano; Mariana Rodrigues Gazzotti; Oliver Augusto Nascimento; Rogelio Perez-Padilla; Ana Maria Baptista Menezes; José Roberto Jardim
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

7.  Clinical significance in COPD patients followed in a real practice.

Authors:  Júlio César Mendes de Oliveira; Isabella de Carvalho Aguiar; Ana Carolina Negrinho de Oliveira Beloto; Israel Reis Santos; Fernando Sergio Studart Leitão Filho; Luciana M Malosa Sampaio; Claudio F Donner; Luís Vicente Franco de Oliveira
Journal:  Multidiscip Respir Med       Date:  2013-06-28

8.  Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.

Authors:  M Bradley Drummond; Gregory D Kirk; Jacquie Astemborski; Meredith C McCormack; Mariah M Marshall; Shruti H Mehta; Robert A Wise; Christian A Merlo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-19

9.  Assessment of five different guideline indication criteria for spirometry, including modified GOLD criteria, in order to detect COPD: data from 5,315 subjects in the PLATINO study.

Authors:  Ana P Luize; Ana Maria B Menezes; Rogelio Perez-Padilla; Adriana Muiño; Maria Victorina López; Gonzalo Valdivia; Carmem Lisboa; Maria Montes de Oca; Carlos Tálamo; Bartolomé Celli; Oliver A Nascimento; Mariana R Gazzotti; José R Jardim
Journal:  NPJ Prim Care Respir Med       Date:  2014-10-30       Impact factor: 2.871

10.  Roflumilast in COPD: a Brazilian perspective.

Authors:  Roberto Stirbulov; José R Jardim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.